Germans Clamor for Covid Vaccines, but Shun AstraZeneca’s Offering

The New York Times | Feb. 25, 2021, 3:41 p.m. | Original

Hundreds of thousands of AstraZeneca doses are sitting unopened as many Germans reject the vaccine over fears it is “second-class” compared to the one developed by BioNTech and Pfizer.

New Covid-19 Infections Have Fallen to Half in Europe, W.H.O. Says The Coronavirus Is Plotting a Comeback. Here’s Our Chance to Stop It for Good.